> Imprima

Dangers of Smokeless Tobacco

Ultima Vez Modificado: 22 de marzo del 2012


My son uses "chew" (smokeless tobacco), is this harmful even though there is no smoking involved?


Gloria DiLullo, MSN, CRNP, OncoLink Content Specialist, responds:

Chew as well as dip, spit, oral/spitless tobacco and dry/moist snuff (snus) are all still tobacco products. Many people mistakenly think smokeless tobacco is a safe alternative to cigarettes and may not realize that it is just as addictive as cigarette smoking. One can of snuff contains the same amount of nicotine as 4 packs of cigarettes and dipping 8 to 10 times, a day introduces as much nicotine into the body as smoking 30-40 cigarettes. The amount of nicotine in the bloodstream after using smokeless tobacco may be higher than that of a cigarette smoker because nicotine is easily and quickly absorbed through the lining of the mouth. In addition, nicotine stays in the bloodstream longer with smokeless tobacco than with cigarettes. Smokeless tobacco also contains many of the carcinogens found in cigarettes.

People who use smokeless tobacco have a higher risk of cancers of the lung, mouth, throat (pharynx), esophagus (swallowing tube from the throat to the stomach), stomach, and pancreas. Other effects of using spit tobacco include chronic bad breath, stained teeth and fillings, gum disease, tooth decay and loss, and break-down of bone in the jaw. Studies show that users of smokeless tobacco also have an increased risk of heart disease, heart attacks, and stroke.

This question and answer was part of the OncoLink Brown Bag Chat Series. View the entire Cancer Risk & Prevention Webchat transcript.

Related News

Cigar Smoking Poses Much the Same Danger As Cigarettes

Apr 28, 2015

All-cause and cause-specific mortality risk increased

Short Time to First Cigarette Ups Head and Neck Cancer Risk

Aug 9, 2011

And, smokers who have first cigarette within one hour of waking are at higher risk for lung cancer

Primary Health Risks Outweigh Long-Term Radiation Concerns

Mar 18, 2013

Results from surveillance of testicular cancer patients are broadly applicable, study finds